France vs Netherlands (Kingdom of the): Percentage of bloodstream infection due to Escherichia coli resistant
France
9.1%
in 2022
Netherlands (Kingdom of the)
7.6%
in 2022
France rank
45th
Netherlands (Kingdom of the) rank
47th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- France
- Netherlands (Kingdom of the)
How they compare
France currently reports 9.1% against 7.6% in Netherlands (Kingdom of the), a difference of 1.5%.
That makes France's figure about 1.2 times Netherlands (Kingdom of the)'s.
Across all 6 years both countries report, France has been ahead every year.
France ranks 45th and Netherlands (Kingdom of the) ranks 47th of 50 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Netherlands (Kingdom of the) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9.6% | 6.9% | 2.7% | France |
| 2020s | 9.5% | 7.0% | 2.5% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, France or Netherlands (Kingdom of the)?
- France, at 9.1% against 7.6% in Netherlands (Kingdom of the) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between France and Netherlands (Kingdom of the)?
- 1.5%, with France ahead.
- How many years of comparable data are there for France and Netherlands (Kingdom of the)?
- 6 years are reported by both, from 2017 to 2022.
- How do France and Netherlands (Kingdom of the) rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- France ranks 45th and Netherlands (Kingdom of the) ranks 47th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.